Happening Tomorrow: Wegovy® Semaglutide Injection 2.4 mg: Advances in MASH: Data From the Phase 3 ESSENCE Study of Wegovy® – Sept. 22nd Posted on September 21, 2026September 18, 2026 Happening Tomorrow_ Wegovy® Semaglutide Injection 2.4 mg_ Advances in MASH_ Data From the Phase 3 ESSENCE Study of Wegovy® – Sept. 22nd